Experienced in Crohn's Disease

Dr. Val R. Hansen

Internal Medicine
520 Medical Dr, Ste 300, 
Bountiful, UT 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Experienced in Crohn's Disease
520 Medical Dr, Ste 300, 
Bountiful, UT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Val Hansen is a primary care provider, practicing in Internal Medicine in Bountiful, Utah. Dr. Hansen is rated as an Experienced provider by MediFind in the treatment of Crohn's Disease. His top areas of expertise are Cerebellar Degeneration, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Hemorrhoidectomy, and Endoscopy. Dr. Hansen is currently accepting new patients.

His clinical research consists of participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 3 clinical trials in the study of Crohn's Disease.

Specialties
Internal Medicine
Licenses
Internal Medicine in UT
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
BridgeSpan
  • EPO
  • HMO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Deseret Mutual Benefit Administrators
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Regence
  • EPO
  • PPO
SelectHealth
  • HMO
  • POS
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Utah Health
  • EPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

520 Medical Dr, Ste 300, Bountiful, UT 84010

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
A Study of Donanemab Versus Placebo in Participants at Risk for Cognitive and Functional Decline of Alzheimer's Disease
Enrollment Status: Recruiting
Publish Date: June 25, 2025
Intervention Type: Drug
Study Drug: Donanemab
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 1b Randomized, Double-Blind, Placebo-Controlled, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy of SER-262 in Adults With Primary Clostridium Difficile Infection (CDI) to Prevent Recurrence
A Phase 1b Randomized, Double-Blind, Placebo-Controlled, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy of SER-262 in Adults With Primary Clostridium Difficile Infection (CDI) to Prevent Recurrence
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 305)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Enrollment Status: Terminated
Publish Date: April 29, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
View 6 Less Clinical Trials
Similar Doctors
Experienced in Crohn's Disease
Dr. Philip Roberts
Internal Medicine
Experienced in Crohn's Disease
Dr. Philip Roberts
Internal Medicine

Mountainstar Medical Group-St. Marks Hospital LLC

74 E Kimballs Ln, Suite 300, 
Draper, UT 
 (24.3 miles away)
801-572-0311
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Philip Roberts is a primary care provider, practicing in Internal Medicine in Draper, Utah. Dr. Roberts is rated as an Advanced provider by MediFind in the treatment of Crohn's Disease. His top areas of expertise are Osteomyelitis in Children, High Cholesterol, Dermatitis Herpetiformis, and Type 2 Diabetes (T2D).

Experienced in Crohn's Disease
Dr. Peter Duros
Internal Medicine
Experienced in Crohn's Disease
Dr. Peter Duros
Internal Medicine

Revere Health - North Orem Internal Medicine

Orem, UT 
 (40.5 miles away)
801-354-8225
Experience:
39+ years
Languages Spoken:
English, German, Russian
See accepted insurances
Accepting New Patients
Offers Telehealth

Peter Duros is a primary care provider, practicing in Internal Medicine in Orem, Utah. Dr. Duros has been practicing medicine for over 39 years and is rated as an Advanced provider by MediFind in the treatment of Crohn's Disease. His top areas of expertise are Type 2 Diabetes (T2D), Osteomyelitis in Children, Hypothyroidism, and Obesity in Children. Dr. Duros is currently accepting new patients.

Experienced in Crohn's Disease
Dr. Michael J. Stones
Internal Medicine
Experienced in Crohn's Disease
Dr. Michael J. Stones
Internal Medicine
Logan, UT 
 (61.5 miles away)
435-792-1980
Languages Spoken:
English
See accepted insurances

Michael Stones is a primary care provider, practicing in Internal Medicine in Logan, Utah. Dr. Stones is rated as an Advanced provider by MediFind in the treatment of Crohn's Disease. His top areas of expertise are Anemia, Wilson Disease, Diabetic Nephropathy, and Sitosterolemia.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hansen's expertise for a condition
ConditionClose
        View All 39 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile